Genzyme Corporate Research Search Genzyme Websites
PatientsHealth Care ProfessionalsPayors
Thyrogen
Patient Overview
Newly Diagnosed
About Thyroid Cancer
Thyroid Cancer Management
Role of Thyrogen
Follow-up
Reimbursement
Resources
Product Information (PDF)

For New Patients

Being diagnosed with cancer can be frightening. But knowledge may help you overcome your fears.

And one of the first things you should know is that, among cancers, thyroid cancer is one of the more treatable. Here are a couple of important facts:

  • The 5-year survival rate of people diagnosed with thyroid cancer is 96%
  • There are 22,000 new cases diagnosed every year

Most importantly, if the disease is detected early and treated appropriately, thyroid cancer can be managed effectively in most patients. There is much more to know about thyroid cancer treatment and management. As always, your doctor or nurse is your best source of information and guidance, but this section will give you a lot of the basics, including an overview of thyroid cancer, how it may be diagnosed, different treatment possibilities, and what you might expect as you carry on with your life.


Safety Information
Thyrogen® (thyrotropin alfa for injection) is used in combination with other tests to detect recurring or leftover thyroid cancer cells in patients with a history of certain types of thyroid cancer. Thyrogen is injected in a muscle, and is available only by prescription. The most common side effects reported in clinical studies were nausea, headache, weakness & vomiting. When using Thyrogen, there is a risk that thyroid cancer cells may not be detected and diagnosis of recurring cancer may be missed. If you think that Thyrogen may be right for you, or if you have any problems with the use of Thyrogen, please contact your doctor. To learn more, please see full product information (PDF), contact Genzyme toll free at 1-88-THYROGEN (1-888-497-6436).
Search Thyrogen
Keyword: 
Search In: 
 
Highlight

Consider the Facts:

Thyroid Cancer is the most common endocrine cancer and occurs in all age groups.

Thyroid Cancer recently was ranked as the #1 cancer in incidence growth in women (National Cancer Institute data).

Thyroid Cancer may recur in up to 30% of patients, even decades after initial diagnosis.

Resources
Related Links
Testing Schedule
Patient Education Materials
Request Materials
Events Calendar
Low-iodine Diet
Glossary
Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
888 497 6436
617 768 8050
Contact Genzyme



 
Thyrogen Terms and Conditions of Use | Privacy Policy | This site is intended for United States residents only © 2003-2008 Genzyme Corporation. All rights reserved. Genzyme